Literature DB >> 33416902

Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.

Maira A Castaneda-Avila1, Christine M Ulbricht1, Mara Meyer Epstein2,3.   

Abstract

Monoclonal gammopathy of undetermined significance (MGUS), precursor of multiple myeloma, is an asymptomatic plasma cell disorder that overproduces serum monoclonal protein. Older age, male sex, black race, and family history of MGUS increase the risk of MGUS, yet other risk factors are known. We systematically reviewed observational epidemiological studies that examined sociodemographic, clinical, and behavioral risk factors for the development of MGUS. The protocol for this study was registered on the PROSPERO registry for systematic reviews. We identified epidemiological studies from PubMed and Scopus. Articles were limited to those written in English and published before February 2019. Five case-control and three cohort studies were eligible for data extraction. Studies evaluating factors associated with MGUS risk are limited, with conflicting conclusions regarding risk associated with obesity. Despite the limited research, a significant elevated risk for being diagnosed with MGUS was associated with several specific prior infections, inflammatory disorders, and smoking. The sparse existing literature suggests an increased risk of MGUS associated with several risk factors related to immune function. Further research is needed to explore the potential mechanisms underlying the development of MGUS and to confirm risk factors, both modifiable and non-modifiable.

Entities:  

Keywords:  MGUS; Risk factors; Systematic review

Mesh:

Substances:

Year:  2021        PMID: 33416902      PMCID: PMC8349467          DOI: 10.1007/s00277-021-04400-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  35 in total

1.  Tobacco smoking and risk of haematological malignancies in adults: a case-control study.

Authors:  P Pasqualetti; V Festuccia; P Acitelli; A Collacciani; A Giusti; R Casale
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

2.  Risk of monoclonal gammopathy of undetermined significance: a case-referent study.

Authors:  P Pasqualetti; A Collacciani; R Casale
Journal:  Am J Hematol       Date:  1996-07       Impact factor: 10.047

3.  Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study.

Authors:  Marianna Thordardottir; Ebba K Lindqvist; Sigrun H Lund; Rene Costello; Debra Burton; Neha Korde; Sham Mailankody; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Tamara B Harris; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-11-01

Review 4.  Cognitive change in heart failure: a systematic review.

Authors:  Alexandra M Hajduk; Catarina I Kiefe; Sharina D Person; Joel G Gore; Jane S Saczynski
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07-09

Review 5.  Differential diagnosis of monoclonal gammopathy of undetermined significance.

Authors:  Giampaolo Merlini; Giovanni Palladini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  Prevalence of monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; Janice R Offord; Angela Dispenzieri; Jerry A Katzmann; L Joseph Melton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

7.  Survival of cancer patients with prior monoclonal gammopathy of undetermined significance.

Authors:  Henrik Gregersen; Henrik Toft Sørensen; Malene Cramer Engebjerg; Paw Jensen; Marianne Tang Severinsen; Mette Nørgaard
Journal:  Eur J Intern Med       Date:  2010-09-19       Impact factor: 4.487

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

10.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01
View more
  5 in total

1.  Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18-40 years old: a possible HIV indicator condition.

Authors:  Michele Bibas; Silvia Pittalis; Nicoletta Orchi; Gabriella De Carli; Chiara Agrati; Enrico Girardi; Andrea Antinori; Vincenzo Puro; Giuseppe Ippolito
Journal:  Blood Cancer J       Date:  2021-05-16       Impact factor: 11.037

2.  Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Vicky C Chang; Ali A Khan; Wen-Yi Huang; Hormuzd A Katki; Mark P Purdue; Ola Landgren; Jonathan N Hofmann
Journal:  Blood Cancer J       Date:  2022-04-01       Impact factor: 11.037

3.  Proteomic profiling of sporadic late-onset nemaline myopathy.

Authors:  Elie Naddaf; Surendra Dasari; Duygu Selcen; M Cristine Charlesworth; Kenneth L Johnson; Michelle L Mauermann; Taxiarchis Kourelis
Journal:  Ann Clin Transl Neurol       Date:  2022-02-20       Impact factor: 4.511

4.  Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster.

Authors:  Rachel Zeig-Owens; David G Goldfarb; David J Prezant; Ola Landgren; Benjamin J Luft; Xiaohua Yang; Kazunori Murata; Lakshmi Ramanathan; Katie Thoren; Sital Doddi; Urvi A Shah; Alexandra K Mueller; Charles B Hall; Orsi Giricz; Amit Verma
Journal:  Blood Cancer J       Date:  2022-08-22       Impact factor: 9.812

5.  Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study.

Authors:  Brian Schwartz; Morten Schou; Frederick L Ruberg; Dane Rucker; Jihoon Choi; Omar Siddiqi; Kevin Monahan; Lars Køber; Gunnar Gislason; Christian Torp-Pedersen; Charlotte Andersson
Journal:  JACC CardioOncol       Date:  2022-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.